SEBI nod for ₹6,250-cr PharmEasy IPO
The API Holdings IPO will entirely be a fresh issue with only a primary share sale of an unspecified number of shares worth ₹6,250 crore.
Stay updated with breaking news from Thyrocare Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The API Holdings IPO will entirely be a fresh issue with only a primary share sale of an unspecified number of shares worth ₹6,250 crore.
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice.
A graduate of IIM-B, Rahul Guha joins API Group to head its Diagnostics Business
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028" report has been added to...
SCDA revealed that it is approaching the Delhi HC to protect the wealth of investors. Here's why SCDA filed this petition.